Compositions and methods of treating melanoma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11576987
SERIAL NO

17507400

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compositions, kits and methods to treat a hyperproliferative disorder with an agent that increases expression of MCR1 and an MCR1 ligand. The invention also provides a method of treating drug-resistant melanoma, comprising administering an MCR1 ligand to a patient in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE UNIVERSITY OF IOWA RESEARCH FOUNDATION

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Johnson, Frances L Iowa City, US 3 4
Kapoor, Somya Iowa City, US 9 15
Lee, Dongyoul Iowa City, US 6 12
Li, Mengshi Iowa City, US 7 17
Martin, Molly Iowa City, US 4 4
Schultz, Michael K Iowa City, US 18 53

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 14, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 14, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 14, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00